XML 46 R30.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of weighted-average assumptions used to estimate the fair values of the stock options granted
       
    Renovaro Inc.
Expected term (in years)     5.06.5  
Volatility     84.33% – 114.88 %
Risk free interest rate     3.12%- 4.83 %
Dividend yield     0 %
Schedule of stock options outstanding
                                    
   Options Outstanding     Options Exercisable
  

Exercise

Price

Ranges

 

Number

Outstanding

 

Weighted

Average

Remaining

Contractual

Life (years)

 

Weighted

Average

Exercise

Price

 

Number

Exercisable

 

Weighted

Average

Remaining

Contractual

Life (years)

 

Weighted

Average

Exercise

Price

   $0.454.50    5,244,987    7.38   $1.89    3,817,105    7.15   $1.92 
    $4.516.50    167,634    6.48   $5.33    135,376    5.81   $5.49 
    $6.5112.00    115,231    4.66   $7.63    111,585    4.57   $7.61 
Total         5,527,852    7.29   $2.11    4,064,066    7.03   $2.20 
Schedule of stock option activity
                     
   Shares  Weighted Average Exercise
Price
  Average Remaining Life  Weighted Average Intrinsic
Value
             
Outstanding at June 30, 2023    4,401,211   $4.78    7.82   $ 
Granted    4,983,572   $1.94           
Exercised       $           
Forfeited       $           
Expired/Canceled     (3,856,931)  $4.94           
Outstanding at June 30, 2024    5,527,852   $2.11    7.30   $ 
Exercisable at June 30, 2024    4,064,066   $2.20    7.05   $525,943 
Schedule of common stock purchase warrants outstanding
                     
   Warrants Outstanding  Warrants Exercisable
  

Exercise

Price

 

Number

Outstanding

 

Weighted

Average

Remaining

Contractual

Life (years)

 

Weighted

Average

Exercise

Price

 

Number

Exercisable

 

Weighted

Average

Remaining

Contractual

Life (years)

 

Weighted

Average

Exercise

Price

    $0.53    471,698    1.33        471,698    1.33     
    $0.65    741,274    3.07        741,274    3.07     
    $1.14    1,189,036    3.73        1,189,036    3.73     
    $1.47    642,128    4.96        642,128    4.96     
    $1.48    50,740    4.99        50,740    4.99     
 Total         3,094,876    3.48   $1.00    3,094,876    3.48   $1.00 
Schedule of warrants outstanding
               
    Shares  Weighted Average Exercise
Price
  Weighted Average Remaining
Life
          
Outstanding at June 30, 2023   3,548,302   $0.73    4.80 
Granted   3,497,918   $0.81    4.27 
Exercised   (3,951,344)  $0.59     
Cancelled/Expired      $     
Outstanding and exercisable at June 30, 2024   3,094,876   $1.00    3.48